EDGAR Filing Documents for 0001209191-17-066626

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-17-066626

Filing Date

2017-12-20

Accepted

2017-12-20 16:14:32

Documents

Period of Report

2017-12-18

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	4000
	Complete submission text file	0001209191-17-066626.txt		5600

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121

Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626

HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HERON THERAPEUTICS, INC 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121

Business Address

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 171266904